22nd Century Group (XXII) Appoints Anthony Johnson to its Board

Go back to 22nd Century Group (XXII) Appoints Anthony Johnson to its Board

22nd Century Group Appoints Accomplished Life Sciences and Biotechnology Executive Anthony Johnson to Board of Directors

August 19, 2021 9:20 AM EDT

Visionary in the Fields of Biotechnology and Genomics to Extend Broad Expertise to Companys Strategy, Technology Development, Commercialization, and Value Creation Efforts

BUFFALO, N.Y., Aug. 19, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced the appointment of Anthony... More